Karyopharm Therapeutics
KPTI
KPTI
79 hedge funds and large institutions have $225M invested in Karyopharm Therapeutics in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 75 → 79 (+4)
Holders
79
Holding in Top 10
–
Calls
$762K
Puts
$186K
Top Buyers
| 1 | +$26.9M | |
| 2 | +$1.53M | |
| 3 | +$1.07M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$754K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$634K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$521K | |
| 3 | -$335K | |
| 4 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$162K |
| 5 |
Bank of New York Mellon
New York
|
-$134K |